Vaccines for preventing typhoid fever
The licensed Ty21a and Vi polysaccharide vaccines are efficacious. The new and unlicensed Vi-rEPA vaccine is as efficacious and may confer longer immunity.
Two typhoid vaccines are commercially available, Ty21a (oral) and Vi polysaccharide (parenteral), but neither is used routinely. Other vaccines, such as a new modified, conjugated Vi vaccine called Vi-rEPA, are in development. This review evaluates vaccines for preventing typhoid fever.
Adults, Both sexes, Child health, Children, Epidemic, Flash flood/Flood, Gastrointestinal infections, Health, Heavy rain, Infections and infectious diseases (all), Logistics, Vaccine-preventable infections, Zoonotic and other parasitic infections